Study finds bone density loss associated with levothyroxine

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn – Pharmaceutical Technology

Eli Lilly (Indianapolis, IN, US) and Novo Nordisk (Bagsvaerd, Denmark) have announced that the supply of their GLP-1 weight loss drugs has improved, with the

August 27, 2024

White House touts incremental step in Medicare drug price negotiation: counteroffers

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort

March 4, 2024

Exploring the link between air quality and mood: a new measure of climate sensitivity

A novel measure, affective sensitivity to air pollution (ASAP), to assess psychological vulnerability to climate change.

August 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.